 Essential thrombocythemia young adults Essential thrombocythemia disorder adults sixth seventh decade life frequent thrombohemorrhagic complications young patients optimal management complications controversial young adults female male patients diagnosis essential thrombocythemia mean duration follow-up years mean platelet count diagnosis Platelet aggregation studies patients demonstrated hypoaggregation spontaneous platelet aggregation present diagnosis patients asymptomatic thrombocytosis follow-up years patients asymptomatic Thrombotic complications patients common vaso-occlusive symptoms migraine headache patients Minor hemorrhagic complications patients none life-threatening Serious complications cerebral myocardial infarctions patients deaths attributable essential thrombocythemia treatment regimens patients agents radioactive phosphorus platelet-lowering agent anagrelide observation treatment-related acute leukemias series young patients essential thrombocythemia date low incidence life-threatening complications favorable long-term prognosis Therapeutic recommendations conservative potential leukemogens serious complications Anagrelide useful young patients thrombocythemia symptomatic